Interview with Former UBS Managing Director and Now COO of StHealth Capital David Lessen.
While
not widely known, Wall Street’s Institutional Investment Managers and Registered
Investment Advisors (RIA’s) love using BDC
Investment Funds for their clients – to the...
StHealth Capital, Our #1 Ranked Emerging BDC Idea.
Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments.
This is easily one of the most exciting...
StHealth Private Equity Medtech Fund. Alternative Investment BDC.
StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with...
Diabasens® to Launch in Europe. Innovus (INNV).
"The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by...
Former Tesla Foundation Vice Chairman Joins StHealth BDC.
St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...
Innovus (INNV) in Silicon Review Interview.
POISED FOR INNOVATION.
The Silicon Review is the world’s most trusted online and print community for business &...
Innovus (INNV) Conference Call Transcript.
Q1 2019 Results, 5/15/19.
Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM...
Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.
The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial...
Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...